Cardio Diagnostics Holdings announced that effective February 21, 2025, its senior management will begin utilizing a new investor presentation for meetings with existing and prospective investors. The presentation materials will be accessible through Exhibit 99.1 of the company's current report.The investor presentation will also be made available on the company's official website at www.cardiodiagnosticsinc.com, providing broader access to stakeholders. The disclosure is being made under Regulation FD requirements, ensuring fair dissemination of information to all market participants.

Cardio Diagnostics Holdings announced that effective February 21, 2025, its senior management will begin utilizing a new investor presentation for meetings with existing and prospective investors. The presentation materials will be accessible through Exhibit 99.1 of the company's current report.The investor presentation will also be made available on the company's official website at www.cardiodiagnosticsinc.com, providing broader access to stakeholders. The disclosure is being made under Regulation FD requirements, ensuring fair dissemination of information to all market participants.